✦ LIBER ✦

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies

✍ Scribed by Shinya Hirabara,Nobunori Takahashi,Naoki Fukaya,Hiroyuki Miyake…

Book ID: 126347429
Publisher: Springer
Year: 2014
Tongue: English
Weight: 446 KB
Volume: 33
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-014-2711-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy of abatacept compared

Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity

✍ Takahashi, Nobunori; Kojima, Toshihisa; Kaneko, Atsushi; Kida, Daihei; Hirano, Y 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 364 KB

PMS5 COST-EFFECTIVENESS OF THE USE OF ET

PMS5 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS ANTI-TNF MONOCLONAL ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO

✍ Aguirre, A; García, E; Bierschwale, H; Arce, CA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PMS35 Cost-Effectiveness of Tocilizumab

PMS35 Cost-Effectiveness of Tocilizumab for the Treatment of Active Rheumatoid Arthritis (RA) Patients With Inadequate Response to Anti-TNF Treatment in Turkey

✍ I. Ertenli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMS9 COST-EFFECTIVENESS OF ABATACEPT IN

PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS):A CANADIAN PERSPECTIVE

✍ M Maier-Moldovan; Y Yuan; R Maclean; GJ L'Italien 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Efficacy of tocilizumab in patients with

Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study

✍ Yazici, Y.; Curtis, J. R.; Ince, A.; Baraf, H.; Malamet, R. L.; Teng, L. L.; Kav 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 301 KB

Longterm Safety and Efficacy of Abatacep

Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy

✍ GENOVESE, M. C.; SCHIFF, M.; LUGGEN, M.; LE BARS, M.; ARANDA, R.; ELEGBE, A.; DO 📂 Article 📅 2012 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 504 KB